Literature DB >> 24410156

Hemorrhagic complications of ventriculostomy: incidence and predictors in patients with intracerebral hemorrhage.

Eric S Sussman1, Christopher P Kellner, Eric Nelson, Michael M McDowell, Samuel S Bruce, Rachel A Bruce, Zong Zhuang, E Sander Connolly.   

Abstract

OBJECT: Ventriculostomy--the placement of an external ventricular drain (EVD)--is a common procedure performed in patients with acute neurological injury. Although generally considered a low-risk intervention, recent studies have cited higher rates of hemorrhagic complications than those previously reported. The authors sought to determine the rate of postventriculostomy hemorrhage in a cohort of patients with intracerebral hemorrhage (ICH) and to identify predictors of hemorrhagic complications of EVD placement.
METHODS: Patients with ICH who underwent EVD placement and had both pre- and postprocedural imaging available for analysis were included in this study. Relevant data were prospectively collected for each patient who satisfied inclusion criteria. Variables with a p < 0.20 on univariate analyses were included in a stepwise logistic regression model to identify predictors of postventriculostomy hemorrhage.
RESULTS: Sixty-nine patients were eligible for this analysis. Postventriculostomy hemorrhage occurred in 31.9% of patients. Among all patients with intraparenchymal hemorrhage, the mean hemorrhage volume was 0.66 ± 1.06 cm(3). Stratified according to ventricular catheter diameter, patients treated with smaller-diameter catheters had a significantly greater mean hemorrhage volume than patients treated with larger-diameter catheters (0.84 ± 1.2 cm(3) vs 0.14 ± 0.12 cm(3), p = 0.049). Postventriculostomy hemorrhage was clinically significant in only 1 patient (1.4%). Overall, postventriculostomy hemorrhage was not associated with functional outcome or mortality at either discharge or 90 days. In the multivariate model, an age > 75 years was the only independent predictor of EVD-associated hemorrhage.
CONCLUSIONS: Advanced age is predictive of EVD-related hemorrhage in patients with ICH. While postventriculostomy hemorrhage is common, it appears to be of minor clinical significance in the majority of patients.

Entities:  

Mesh:

Year:  2014        PMID: 24410156     DOI: 10.3171/2013.12.JNS131685

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

1.  Hemorrhage Rate After External Ventricular Drain Placement in Subarachnoid Hemorrhage: Time to Heparin Administration.

Authors:  Andrew P Gard; Brian D Sayles; J Will Robbins; William E Thorell; Daniel L Surdell
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

2.  Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention.

Authors:  Bhiken I Naik; Ellen C Keeley; Daryl R Gress; Zhiyi Zuo
Journal:  Anesthesiology       Date:  2014-09       Impact factor: 7.892

3.  The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III Trial.

Authors:  Achim Müller; W Andrew Mould; W David Freeman; Nichol McBee; Karen Lane; Rachel Dlugash; Rick Thompson; Saman Nekoovaght-Tak; Vikram Madan; Hasan Ali; Agnieszka Stadnik; Issam Awad; Daniel Hanley; Wendy C Ziai
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

4.  Hemorrhagic Complications Associated with Ventriculostomy in Patients Undergoing Endovascular Treatment for Intracranial Aneurysms: A Single-Center Experience.

Authors:  Jack M Leschke; Andrew Lozen; Mayank Kaushal; Akinwunmi Oni-Orisan; Mazen Noufal; Osama Zaidat; Glen A Pollock; Wade M Mueller
Journal:  Neurocrit Care       Date:  2017-08       Impact factor: 3.210

5.  Symptomatic Hemorrhagic Complications in Clot Lysis: Evaluation of Accelerated Resolution of Intraventricular Hemorrhage Phase III Clinical Trial (CLEAR III): A Posthoc Root-Cause Analysis.

Authors:  Maged D Fam; Agnieszka Stadnik; Hussein A Zeineddine; Romuald Girard; Steven Mayo; Rachel Dlugash; Nichol McBee; Karen Lane; W Andrew Mould; Wendy Ziai; Daniel Hanley; Issam A Awad
Journal:  Neurosurgery       Date:  2018-12-01       Impact factor: 4.654

6.  Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.

Authors:  Jennifer A Frontera; Errol Gordon; Victor Zach; Maximo Jovine; Ken Uchino; Muhammad S Hussain; Louis Aledort
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

7.  A nomogram to predict the risk of postoperative intracranial rebleeding in patients with spontaneous intracranial hematoma.

Authors:  Junhua Yang; Yang Liu; Qingyuan Liu; Kaiwen Wang; Shaohua Mo; Maogui Li; Jun Wu; Pengjun Jiang; Shuzhe Yang; Rui Guo; Yi Yang; Jiaming Zhang; Yong Cao; Shuo Wang
Journal:  Neurosurg Rev       Date:  2021-10-29       Impact factor: 3.042

Review 8.  The Insertion and Management of External Ventricular Drains: An Evidence-Based Consensus Statement : A Statement for Healthcare Professionals from the Neurocritical Care Society.

Authors:  Herbert I Fried; Barnett R Nathan; A Shaun Rowe; Joseph M Zabramski; Norberto Andaluz; Adarsh Bhimraj; Mary McKenna Guanci; David B Seder; Jeffrey M Singh
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

9.  Minimally invasive therapeutic ultrasound: Ultrasound-guided ultrasound ablation in neuro-oncology.

Authors:  Micah Belzberg; Smruti Mahapatra; Alexander Perdomo-Pantoja; Francisco Chavez; Kyle Morrison; Kah Timothy Xiong; Nao J Gamo; Stephen Restaino; Nitish Thakor; Youseph Yazdi; Rajiv Iyer; Betty Tyler; Nicholas Theodore; Mark G Luciano; Henry Brem; Mari Groves; Alan R Cohen; Amir Manbachi
Journal:  Ultrasonics       Date:  2020-06-20       Impact factor: 2.890

10.  Brain-Relaxing Effect of Different Diuretic Regimens in Supratentorial Tumor Surgery: A Comparative Study Guided by Optic Nerve Sheath Diameter.

Authors:  Mohamed Adel Aboelela; Alrefaey Kandeel Alrefaey
Journal:  Anesth Essays Res       Date:  2021-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.